Nordström A L, Farde L, Wiesel F A, Forslund K, Pauli S, Halldin C, Uppfeldt G
Department of Psychiatry and Psychology, Karolinska Institute, Stockholm, Sweden.
Biol Psychiatry. 1993 Feb 15;33(4):227-35. doi: 10.1016/0006-3223(93)90288-o.
The relationship between central D2-dopamine receptor occupancy and antipsychotic drug effects was examined in a double-blind study. Raclopride was the compound used to induce a selective occupancy of the D2-dopamine receptors. In addition, 11C-labeled raclopride was the radioligand used to measure occupancy by positron emission tomography (PET). Seventeen schizophrenic patients were randomly assigned to one of three parallel groups treated for 4 weeks with daily doses of 2, 6, or 12 mg of raclopride. D2-receptor occupancy was determined by PET at steady-state conditions in 13 patients who completed the study. A statistically significant relationship was demonstrated between antipsychotic effect and degree of D2-receptor occupancy (p < 0.05). Patients with extrapyramidal side effects had significantly higher D2-receptor occupancy than those without (p = 0.02). The finding of a relationship between selective occupancy of the D2-dopamine receptors and clinical effects in schizophrenic patients principally provides new support for the dopamine hypothesis of antipsychotic drug action.
在一项双盲研究中,对中枢D2-多巴胺受体占有率与抗精神病药物疗效之间的关系进行了研究。雷氯必利是用于诱导D2-多巴胺受体选择性占有率的化合物。此外,11C标记的雷氯必利是用于通过正电子发射断层扫描(PET)测量占有率的放射性配体。17名精神分裂症患者被随机分配到三个平行组之一,每天服用2、6或12毫克雷氯必利,治疗4周。在完成研究的13名患者中,通过PET在稳态条件下测定D2受体占有率。抗精神病作用与D2受体占有率程度之间存在统计学上的显著关系(p < 0.05)。有锥体外系副作用的患者的D2受体占有率显著高于无锥体外系副作用的患者(p = 0.02)。在精神分裂症患者中,D2-多巴胺受体的选择性占有率与临床效果之间存在关系这一发现,主要为抗精神病药物作用的多巴胺假说提供了新的支持。